KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Taxes: 2012-2024

Historic Change in Taxes for Jazz Pharmaceuticals (JAZZ) over the last 13 years, with Dec 2024 value amounting to -$14.7 million.

  • Jazz Pharmaceuticals' Change in Taxes rose 515.96% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.2 million, marking a year-over-year increase of 334.63%. This contributed to the annual value of -$14.7 million for FY2024, which is 158.45% down from last year.
  • As of FY2024, Jazz Pharmaceuticals' Change in Taxes stood at -$14.7 million, which was down 158.45% from $25.2 million recorded in FY2023.
  • In the past 5 years, Jazz Pharmaceuticals' Change in Taxes registered a high of $25.2 million during FY2023, and its lowest value of -$15.5 million during FY2021.
  • Its 3-year average for Change in Taxes is $2.9 million, with a median of -$1.7 million in 2022.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Change in Taxes tumbled by 219.07% in 2021, and later skyrocketed by 1,590.54% in 2023.
  • Yearly analysis of 5 years shows Jazz Pharmaceuticals' Change in Taxes stood at $13.0 million in 2020, then crashed by 219.07% to -$15.5 million in 2021, then spiked by 89.10% to -$1.7 million in 2022, then skyrocketed by 1,590.54% to $25.2 million in 2023, then slumped by 158.45% to -$14.7 million in 2024.